Phase

phase 2 (2,016)

phase 1 (716)

phase 3 (597)

phase 1/phase 2 (485)

n/a (470)

phase 4 (131)

phase 2/phase 3 (74)

early phase 1 (47)

Study Documents

Individual Participant Data Set (13)

Study Protocol (13)

Clinical Study Report (12)

Informed Consent Form (12)

Statistical Analysis Plan (11)

Dataset Specification (10)

Annotated Case Report Form (9)

Study-level clinical trial data (2)

Mutation data (1)

Funder Type

Other (3,507)

Industry (1,942)

NIH (74)

U.S. Fed (7)

Study Type

Interventional (4,536)

Observational (863)

Observational [Patient Registry] (97)

Expanded Access (34)

transformed SCLC, EGFR-mutated NSCLC

Showing 5526 - 5530 of 5,530

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Previously Treated Metastatic NSCLC Trial in Jacksonville, Orange Park (Oxaliplatin)

Unknown status

Previously Treated Metastatic Non-Small Cell Lung Cancer

Oxaliplatin

Jacksonville, Florida
+1 more

Oct 13, 2005

Mutations of Vulnerability Genes of Schizophrenia

Unknown status

Schizophrenia

Taipei, Taiwan

National Taiwan University Hospital

Nov 25, 2005

NSCLC Trial in Gdansk (celecoxib)

Suspended

Non-Small Cell Lung Cancer

celecoxib

Gdansk, Poland

Medical University of Gdansk

Sep 13, 2005

Lung Cancer Trial (platinum-based chemo alone (up to six cycles), platinum-based chemo followed by maintenance therapy with

Completed

Lung Cancer

platinum-based chemotherapy alone (up to six cycles)
platinum-based chemotherapy followed by maintenance therapy with gefitinib

(no location specified)

Sep 1, 2005

NSCLC Trial in Ann Arbor (PET scan use in radiotherapy planning)

Completed

Carcinoma, Non-Small-Cell Lung

PET scan use in radiotherapy planning

Ann Arbor, Michigan

UH B2 C490 Box 0010 E. Medical Center Drive

Jun 23, 2005